Metabolic liver disease in the young adult

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 17, Issue 2, 2003, Pages 307-322

  Mailliard, Mark E ^a   Gollan, John L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cystic fibrosis; Haemochromatosis; Liver disease; Wilson disease; 1 anti trypsin

Indexed keywords

ADULT; AGE; ALPHA 1 ANTITRYPSIN DEFICIENCY; CYSTIC FIBROSIS; GENETICS; HEMOCHROMATOSIS; HUMAN; MUTATION; PHENOTYPE; REVIEW; WILSON DISEASE; ADULTHOOD; GENE MUTATION; GENETIC SCREENING; GENOTYPE; LIVER DISEASE; METABOLIC DISORDER; PHENOTYPIC VARIATION; PREDICTION; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; SIDE EFFECT; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; LIVER BIOPSY; PHLEBOTOMY; PREVALENCE; SCREENING; UNITED STATES;

ADULT; AGE FACTORS; ALPHA 1-ANTITRYPSIN DEFICIENCY; CYSTIC FIBROSIS; HEMOCHROMATOSIS; HEPATOLENTICULAR DEGENERATION; HUMANS; MUTATION; PHENOTYPE;

ALPHA 1 ANTITRYPSIN; BIOCHEMICAL MARKER; PENICILLAMINE; TRIENTINE; URSODEOXYCHOLIC ACID; VITAMIN; ZINC ACETATE; CERULOPLASMIN;

EID: 0041408817     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6918(02)00148-8     Document Type: Review

References (84)

1. Balistreri W.F. Liver disease in infancy and childhood In Schiff E.R. Sorrell M.F. & Maddrey W.C. (Eds.), Schiff's Diseases of the Liver 8th edn 1999 1357-1512 Lippincott-Raven Publishers Philadelphia
2. Rosen HR and Martin P (eds). Metabolic Liver Disease. Clinics in Liver Disease 1998; 2: 1-210.
3. Bezerra JA, Balistreri WF (eds). Hepatobiliary disorders of childhood: pathophysiology, clinical features and treatment. Seminars in Liver Disease 1998; 18: 193-307.
4. Sokol RJ & Feranchak AP (eds).Genetic and metabolic basis of pediatric liver diseases. Seminars in Liver Disease 2001; 21: 469-578.
5. Pietrangelo A. Physiology of iron transport and the hemochromatosis gene American Journal of Physiology: Gastrointestinal and Liver Physiology 282 2002 G403-G414
6. Andres N.C. Fleming M.D. Phil D. Levy J.E. Molecular insights into mechanisms of iron transport Current Opinion in Hematology 6 1999 61-64
7. Beutler E. Felitti V.J. Koziol J.A. et al. Penetrance of 845G to A (C282Y) HFE hereditary hemochromatosis mutation in the USA Lancet 359 2002 211-218
8. Waalen J. Felitti V.J. Gelbart T. et al. Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene Mayo Clinic Proceedings 77 2002 522-530
9. Sheldon J.H. Hemochromatosis 1935 Oxford University Press London
10. Niederau C. Fischer R. Purschel A. et al. Long-term survival in patients with hereditary hemochromatosis Gastroenterology 110 1996 1107-1119
11. Niederau C. Fischer R. Sonnenberg A. et al. Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis New England Journal of Medicine 313 1985 1256-1262
12. Adams P.C. Speechley M. Kertesz A.E. Long-term survival analysis in hereditary hemochromatosis Gastroenterology 101 1991 368-372
13. Britton R.S. Fleming R.E. Pakkila S. et al. Pathogenesis of hereditary hemochromatosis: genetics and beyond Seminars in Gastrointestinal Disease 2 2002 68-79
14. Kelly A.J. Rhodes D.A. Roland J.M. et al. Hereditary juvenile hemochromatosis: a genetically heterogeneous life-threatening iron-storage disease Quarterly Journal of Medicine 91 1998 607-618
15. Camaschella C. Roetto A. The gene TfR2 is mutated in a new type of hemochromatosis mapping to 7q22 Nature Genetics 25 2000 14-15
16. Girelli D. Bozzini C. Roetto A. et al. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferring receptor 2 gene Gastroenterology 122 2002 1295-1302
17. Montosi G. Donovan A. Totaro A. et al. Autosomal-dominant haemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene Journal of Clinical Investigation 108 2001 619-623
18. Feder J.N. Gnirke A. Thomas W. et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis Nature Genetics 13 1996 399-408
19. Lebron J.A. Bennett M.J. Vaughn D.E. et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with the transferrin receptor Cell 93 1998 111-123
20. Wallace D.F. Walker A.P. Pietrangelo A. et al. Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y Journal of Hepatology 36 2002 474-479
21. Camaschella C. Natural history of juvenile hemochromatosis British Journal of Hematology 117 2002 973-979
22. Camaschella C. Juvenile haemochromatosis Baillière's Clinical Gastroenterology 12 1998 227-235
23. Haddy T.B. Castro O.L. Rana S.R. Hereditary hemochromatosis in children, adolescents and young adults American Journal of Pediatrics: (Hematology and Oncology) 10 1988 23-34
24. Manhem S. Salmon A.P. Dennet X. Hemochromatosis presenting as severe cardiac failure in a young adolescent International Journal of Cardiology 29 1990 86-89
25. Adams P.C. Deugnier Y. Moir R. Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis Hepatology 25 1997 162-166
26. Adams P.C. Kertesz A.E. Valberg L.S. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness Hepatology 122 1995 1720-1727
27. Allen K. Williamson R. Should we genetically test everyone for hemochromatosis? Journal of Medical Ethics 25 1999 209-214
28. Niederau C. Strohmeyer G. Strategies for early diagnosis of hemochromatosis European Journal of Gastroenterology and Hepatology 14 2002 217-221
29. Powell L.W. Yapp T.R. Hemochromatosis Clinics in Liver Disease 4 2000 211-228
30. Nowicki M. Bacon B.R. Hereditary hemochromatosis in siblings: diagnosis by genotyping Pediatrics 105 2000 426-429
31. Seamark C.J. Hutchinson M. Controversy in primary care: should asymptomatic hemochromatosis be treated? British Medical Journal 320 2000 1314-1317
32. Brandhagen D.J. Liver transplantation for hereditary hemochromatosis Liver Transplantation 7 2001 663-672
33. Poulos J.E. Bacon B.R. Liver transplantation for hereditary hemochromatosis Liver Transplantation and Surgery 14 1996 316-322
34. Sternlieb I. Wilson's disease Clinics in Liver Disease 4 2000 229-239
35. Stremmel W. Meyerros K.W. Niederau C. et al. Wilson disease: clinical presentation, treatment, and survival Annals of Internal Medicine 115 1991 720-726
36. Schilsky K.L. Wilson disease: genetic basis of copper toxicity and natural history Seminars in Liver Disease 16 1996 83-95
37. Brewer G.J. Recognition, diagnosis and management of Wilson's disease Proceedings of the Society of Experimental Biology and Medicine 223 2000 39-46
38. Gollan J.L. Gollan T.J. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects Journal of Hepatology 28 1998 28-36
39. Hamza I. Gitlin J.D. Copper metabolism and the liver In Arias I.M. (Ed.), The Liver: Biology and Pathobiology 4th edn 2001 331-343 Lippincott, Williams and Wilkins Philadelphia
40. Frydman M. Bonne-Tamir B. Farrer L.A. et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus Proceedings of the National Academy of Sciences of the USA 82 1985 1819-1821
41. Riordan S.M. Willliams R. The Wilson's disease gene and phenotypic diversity Journal of Hepatology 34 2001 165-171
42. Saito T. Presenting symptoms and natural history of Wilson disease European Journal of Pediatrics 146 1987 261-265
43. Gow P.J. Smallwood R.A. Angus P.W. et al. Diagnosis of Wilson's disease: an experience over three decades Gut 46 2000 261-265
44. Lau J.Y. Lai C.L. Wu P.C. Wilson's disease: 35 years experience Quarterly Journal of Medicine 75 1990 597-605
45. Ferlan-Marolt V. Stepec S. Fulminant Wilsonian hepatitis unmasked by disease progression Digestive Diseases and Sciences 44 1999 1054-1058
46. Pashankar D. Schreiber R.A. Jaundice in older children and adolescents Pediatrics in Review 22 2001 219-226
47. Uhl M.D. Riely C.A. Unusual causes of acute liver failure In Lee W.M. & Williams R. (Eds.), Acute Liver Failure 1977 42-53 Cambridge University Press Cambridge
48. Oder W. Prayer L. Grimm G. et al. Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions Neurology 43 1993 120-124
49. Walshe J.M. Yealland M. Not Wilson's disease: a review of misdiagnosed cases Quarterly Journal of Medicine 88 1994 55-59
50. Oder W. Grimm G. Kollegger H. et al. Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases Journal of Neurology 238 1991 281-287
51. Ludwig J. Moyer T.P. Rakela J. The liver biopsy diagnosis of Wilson's disease American Journal of Clinical Pathology 102 1994 443-446
52. Nash S. Marconi S. Sikorska K. et al. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing American Journal of Clinical Pathology 118 2002 73-81
53. McCullough A.J. Fleming C.R. Thistle J.L. et al. Diagnosis of Wilson's disease presenting as fulminant hepatic failure Gastroenterology 84 1983 161-167
54. Berman D.H. Leventhal R.I. Gavaler J.S. et al. Clinical differentiation of fulminant Wilsonian hepatitis from the other causes of hepatic failure Gastroenterology 100 1991 1129-1134
55. Schilsky M.L. The irony of treating Wilson's disease American Journal of Gastroenterology 96 2001 3055-3057
56. Schilsky M.L. Wilson's disease Clinical Perspectives in Gastroenterology 5 2002 234-243
57. Brewer G.J. Askari F. Transplant livers in Wilson's disease for hepatic, not neurologic, indications Liver Transplantation and Surgery 6 2000 662-664
58. Eghstead B. Nezakargoo N. Geraci L.C. et al. Liver transplantation for Wilson's disease: a single center experience Liver Transplantation and Surgery 5 1999 467-474
59. Perlmutter D.H. Liver injury in alpha 1-antitrypsin deficiency Clinics in Liver Disease 4 2000 387-408
60. Eriksson S. Alpha 1-antitrypsin deficiency Journal of Hepatology 30 1999 34-39
61. Eriksson S. Elzouki A.N. Alpha 1-antitrypsin deficiency Baillière's Clinical Gastroenterology 12 1998 257-273
62. Carrell R.W. Lomas D.A. Alpha1-antitrypsin deficiency-a model for conformational diseases New England Journal of Medicine 346 2002 45-53
63. Libert C. Van Molle W. Brouckaert P. et al. Alpha1-antitrypsin inhibits the lethal response to TNF in mice Journal of Immunology 157 1996 5126-5129
64. Lomas D.A. Evans D.L. Finch J.T. Carrell R.W. The mechanism of Z 1-antitrypsin accumulation in the liver Nature 357 1992 605-607
65. Eriksson S. Carlson J. Velez R. Risk of cirrhosis and primary liver cancer in alpha1-antitrypsin deficiency New England Journal of Medicine 314 1986 736-739
66. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200, 000 infants New England Journal of Medicine 294 1976 1316-1321
67. Sveger T. Eriksson S. The liver in adolescents with 1-antitrypsin deficiency Hepatology 2 1995 514-517
68. Zhou H. Fischer H.P. Liver carcinoma in PiZ alpha-1-antitrypsin deficiency American Journal of Surgical Pathology 22 1998 742-748
69. Feranchak A.P. Sokol R.J. Cholangiocyte biology and cystic fibrosis liver disease Seminars in Liver Disease 21 2001 471-488
70. Lindblad A. Glaumann H. Strandvik B. Natural history of liver disease in cystic fibrosis Hepatology 30 1999 1151-1158
71. Wilschanski M. Rivlin J. Cohen S. et al. Clinical and genetic risk factors for cystic fibrosis-related liver disease Pediatrics 103 1999 52-57
72. Sokol R.J. Durie P.R. Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group Journal of Pediatric Gastroenterology and Nutrition 28 1999 1-13
73. The Cystic Fibrosis Genotype-Phenotype Consortium Correlation between genotype and phenotype in patients with cystic fibrosis New England Journal of Medicine 329 1993 1308-1313
74. Tanner M.S. Taylor C.J. Liver disease in cystic fibrosis Archives of Diseases in Childhood 72 1995 281-284
75. Colombo C. Battezzati P.M. Strazzabosco M. et al. Liver and biliary problems in cystic fibrosis Seminars in Liver Disease 18 1998 227-235
76. Colombo C. Crosignani A. Battezzati P.M. Liver involvement in cystic fibrosis Hepatology 31 1999 946-954
77. Ling S.C. Wilkinson J.D. Hollman A.S. et al. The evolution of liver disease in cystic fibrosis Archives of Diseases in Childhood 81 1999 129-132
78. Modolell I. Alvarez A. Guarner L. et al. Gastrointestinal, liver, and pancreatic involvement in adult patients with cystic fibrosis Pancreas 22 2001 395-399
79. Colombo C. Battezzati P.M. Podda M. et al. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis Hepatology 23 1996 1484-1490
80. Lindblad A. Glaumann H. Strandvik B. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease Hepatology 27 1998 166-174
81. Lazaridis K.N. Gores G.J. Lindor K.D. Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders Journal of Hepatology 35 2001 134-146
82. Paumgartner G. Beurs U. Ursodeoxycholic acid and cholestatic liver disease: mechanism of action and therapeutic use revisited Hepatology 36 2002 525-531
83. Sharp H.L. Cystic fibrosis liver disease and transplantation Journal of Pediatrics 127 1995 944-946
84. Chavez-Cartaya R. Drage M. Jamieson N.V. et al. Biliary complications in liver transplantation for cystic fibrosis Transplant Proceedings 31 1999 2411-2412